Attention Bias Modification Treatment (ABMT) for Patients With Post Traumatic Stress Disorder (PTSD)

Tel Aviv University

Status and phase: Completed; Phase 2

Conditions: Attention Bias Modification Treatment (ABMT)

Treatments: Behavioral: Attention Bias Modification Treatment (ABMT)

Study type: Interventional

Funder types: Other

Identifiers

NCT01368302

949-2010

Details and patient eligibility

About

Patients with Post Traumatic Stress Disorder (PTSD) will be randomly assigned to either Attention Bias Modification Treatment (ABMT) designed to normalize threat-related attention biases or a placebo control condition not designed to change attention patterns. Outcome measures will be Post Traumatic Stress Disorder (PTSD), depression, and anxiety symptoms as measured by gold standard questionnaires and symptom counts derived from structured clinical interviews.

We expect to see significant Post Traumatic Stress Disorder symptom reduction in the Attention Bias Modification Treatment (ABMT) group relative to the placebo control group in which no symptomatic relief is expected.

Enrollment: 52 patients

Sex: Male

Volunteers: No Healthy Volunteers

Inclusion criteria

• Combat-related PTSD diagnosis

Exclusion criteria

• Other treatment

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: Quadruple Blind

---

52 participants in 2 patient groups, including a placebo group

Attention Bias Modification (ABM)

Experimental group

Description:

Attention training via repeated trials of a dot-probe task intended to normalize threat-related attention biases.

Treatment:

Behavioral: Attention Bias Modification Treatment (ABMT)

Placebo

Placebo Comparator group

Description:

Attention training via repeated trials of a dot-probe task not intended to change threat-related attention patterns.

Treatment:

Behavioral: Attention Bias Modification Treatment (ABMT)